|
1
|
Rabinovitch M, Haworth SG, Castaneda AR,
Nadas AS and Reid LM: Lung biopsy in congenital heart disease: a
morphometric approach to pulmonary vascular disease. Circulation.
58:1107–1122. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Loscalzo J: Endothlial dysfuntion in
pulmonary hypertension. N Engl J Med. 327:117–119. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tuder RM, Marecki JC, Richter A,
Fijalkowska I and Flores S: Pathology of pulmonary hypertension.
Clin Chest Med. 28:23–42. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Humbert M, Morrell NW, Archer SL and
Stenmark KR: Cellular and molecular pathobiology of pulmonary
arterial hypertension. J Am Coll Cardiol. 43:13S–24S. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Price LC, Wort SJ, Perros F, et al:
Inflammation in pulmonary arterial hypertension. Chest.
141:210–221. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Quarck R, Nawrot T, Meyns B and Delcroix
M: C-reactive protein: a new predictor of adverse outcome in
pulmonary arterial hypertension. J Am Coll Cardiol. 53:1211–1218.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li M, Tan Y, Stenmark KR and Tan W: High
pulsatility flow induces acute endothelial inflammation through
overpolarizing cells to activate NF-κB. Cardiovasc Eng Technol.
4:26–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sen R and Baltimore D: Multiple nuclear
factors interact with the immunoglobulin enhancer sequences. Cell.
46:705–716. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen F, Castranova V, Shi X and Demers LM:
New insights into the role nuclear factor kappaB, a ubiquitous
transcription factor in the initiation of diseases. Clin Chem.
45:7–17. 1999.PubMed/NCBI
|
|
10
|
Adib-Conquy M, Adrie C, Moine P, et al: NF
kappaB expression in mononuclear cells of patients with sepsis
resembles that observed in lipopolysaccharide tolerance. Am J
Respir Crit Care Med. 162:1877–1883. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lan Q, Mercurius KO and Davies PF:
Stimulation of transcription factors NF kappa B and AP1 in
endothelial cells subjected to shear stress. Biochem Biophys Res
Commun. 201:950–956. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nagel T, Resnick N, Dewey CF Jr and
Gimbrone MA Jr: Vascular endothelial cells respond to spatial
gradients in fluid shear stress by enhanced activation of
transcription factors. Arterioscler Thromb Vasc Biol. 19:1825–1834.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Davies RJ, Holmes AM, Deighton J, et al:
BMP type II receptor deficiency confers resistance to growth
inhibition by TGF-β in pulmonary artery smooth muscle cells: role
of proinflammatory cytokines. Am J Physiol Lung Cell Mol Physiol.
302:L604–L615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Price LC, Caramori G, Perros F, et al:
Nuclear factor κB is activated in the pulmonary vessels of patients
with end-stage idiopathic pulmonary arterial hypertension. PLoS
One. 8:e754152013. View Article : Google Scholar
|
|
15
|
Bartman T and Hove J: Mechanics and
function in heart morphogenesis. Dev Dyn. 233:373–381. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mironov V, Visconti RP and Markwald RR: On
the role of shear stress in cardiogenesis (Review). Endothelium.
12:259–261. 2005. View Article : Google Scholar
|
|
17
|
Yamamoto H, Teramoto H, Uetani K, Igawa K
and Shimizu E: Cyclic stretch upregulates interleukin-8 and
transforming growth factor-betal production through a protein
kinase C-dependent pathway in alveolar epithelial cells.
Respirology. 7:103–109. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vlahakis NE, Schroeder MA, Limper AH and
Hubmayr RD: Stretch induces cytokine release by alveolar epithelial
cells in vitro. Am J Physiol. 277:L167–L173. 1999.PubMed/NCBI
|
|
19
|
Zheng JP, Zhang Y, Edvinsson L, Hjalt T
and Xu CB: NF-kappaB signaling mediates vascular smooth muscle
endothelin type B receptor expression in resistance arteries. Eur J
Pharmacol. 637:148–154. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schermuly RT, Dony E, Ghofrani HA, et al:
Reversal of experimental pulmonary hypertension by PDGF inhibition.
J Clin Invest. 115:2811–2821. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Merklinger SL, Jones PL, Martinez EC and
Rabinovitch M: Epidermal growth factor receptor blockade mediates
smooth muscle cell apoptosis and improves survival in rats with
pulmonary hypertension. Circulation. 112:423–431. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sakao S, Taraseviciene-Stewart L, Cool CD,
et al: VEGF-R blockade causes endothelial cell apoptosis, expansion
of surviving CD34+ precursor cells and
transdifferentiation to smooth muscle-like and neuronal-like cells.
FASEB J. 21:3640–3652. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tuder RM, Cool CD, Geraci MW, et al:
Prostacyclin synthase expression is decreased in lungs from
patients with severe pulmonary hypertension. Am J Respir Crit Care
Med. 159:1925–1932. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Matsui H, Shimosawa T, Itakura K, Guanqun
X, Ando K and Fujita T: Admnomedullin can protect against pulmonary
vascular remodeling induced by hypoxia. Circulation. 109:2246–2251.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Couture R, Blaes N and Girolami JP: Kinin
receptors in vascular biology and pathology. Curr Vasc Pharmacol.
12:223–248. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yeh PY, Li CY, Hsieh CW, Yang YC, Yang PM
and Wung BS: CO-releasing molecules and increased heme oxygenase-1
induce protein S-glutathionylation to modulate NF-κB activity in
endothelial cells. Free Radic Biol Med. 70:1–13. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang YH, Xiang RL, Hu XT, et al: Changes
of serum leptin and vascular endothelial growth factor in children
with congenital heart disease. Zhongguo Dang Dai Er Ke Za Zhi.
11:802–804. 2009.(In Chinese). PubMed/NCBI
|
